Association of PD-1, PD-L1, and CTLA-4 Gene Expression and Clinicopathologic Characteristics in Patients With Non-Small-Cell Lung Cancer

Autor: Lafuente-Sanchis A, Zúñiga Á, Estors M, Martínez-Hernández NJ, Cremades A, Cuenca M, Galbis JM

Publikováno v: Clinical Lung Cancer
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Clinicopathologic characteristics of patients with nonesmall-cell lung cancer (NSCLC) related to positive responses to immunotherapy are currently unknown. In our study, we found that alterations in programmed death receptor 1 (PD-1)/programmed death

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::759bbfd14d03309d074c80c569056004
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1746

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma.

Autor: Duch P; Department of Biomedicine, School of Medicine and Health Sciences, Unit of Biophysics and Bioengineering, University of Barcelona, Barcelona, Spain., Díaz-Valdivia N; Department of Biomedicine, School of Medicine and Health Sciences, Unit of Biophysics and Bioengineering, University of Barcelona, Barcelona, Spain., Gabasa M; Department of Biomedicine, School of Medicine and Health Sciences, Unit of Biophysics and Bioengineering, University of Barcelona, Barcelona, Spain.; Thoracic Oncology Unit, Hospital Clinic Barcelona, Barcelona, Spain., Ikemori R; Department of Biomedicine, School of Medicine and Health Sciences, Unit of Biophysics and Bioengineering, University of Barcelona, Barcelona, Spain., Arshakyan M; Department of Biomedicine, School of Medicine and Health Sciences, Unit of Biophysics and Bioengineering, University of Barcelona, Barcelona, Spain., Fernández-Nogueira P; Department of Biomedicine, School of Medicine and Health Sciences, Unit of Biophysics and Bioengineering, University of Barcelona, Barcelona, Spain., Llorente A; Department of Biomedicine, School of Medicine and Health Sciences, Unit of Biophysics and Bioengineering, University of Barcelona, Barcelona, Spain., Teixido C; Thoracic Oncology Unit, Hospital Clinic Barcelona, Barcelona, Spain.; Pathology Service, Hospital Clinic Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Ramírez J; Thoracic Oncology Unit, Hospital Clinic Barcelona, Barcelona, Spain.; Pathology Service, Hospital Clinic Barcelona, Barcelona, Spain.; Biomedical Research Center Network for Respiratory Diseases (CIBERES), Carlos III Health Institute, Madrid, Spain., Pereda J; Department of Physiology, Faculty of Pharmacy, University of Valencia, Burjassot, Spain., Chuliá-Peris L; Department of Physiology, Faculty of Pharmacy, University of Valencia, Burjassot, Spain., Galbis JM; Thoracic Surgery Service, Ribera University Hospital, Alzira, Spain., Hilberg F; Boehringer Ingelheim Austria RCV GmbH & Co. KG, Vienna, Austria., Reguart N; Thoracic Oncology Unit, Hospital Clinic Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Radisky DC; Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida, USA., Alcaraz J; Department of Biomedicine, School of Medicine and Health Sciences, Unit of Biophysics and Bioengineering, University of Barcelona, Barcelona, Spain.; Thoracic Oncology Unit, Hospital Clinic Barcelona, Barcelona, Spain.; Biomedical Research Center Network for Respiratory Diseases (CIBERES), Carlos III Health Institute, Madrid, Spain.; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), Barcelona, Spain.

Publikováno v: Cancer science [Cancer Sci] 2024 May; Vol. 115 (5), pp. 1505-1519. Date of Electronic Publication: 2024 Mar 12.

In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer.

Autor: Milián L; Department of Pathology, Faculty of Medicine and Dentistry, Universitat de València, 46010 Valencia, Spain.; INCLIVA Biomedical Research Institute, 46010 Valencia, Spain., Monleón-Guinot I; Department of Pathology, Faculty of Medicine and Dentistry, Universitat de València, 46010 Valencia, Spain.; INCLIVA Biomedical Research Institute, 46010 Valencia, Spain., Sancho-Tello M; Department of Pathology, Faculty of Medicine and Dentistry, Universitat de València, 46010 Valencia, Spain.; INCLIVA Biomedical Research Institute, 46010 Valencia, Spain., Galbis JM; Hospital de la Ribera, 46600 Alzira, Spain., Cremades A; Hospital de la Ribera, 46600 Alzira, Spain., Almenar-Ordaz M; Department of Pathology, Faculty of Medicine and Dentistry, Universitat de València, 46010 Valencia, Spain., Peñaroja-Martinez J; Department of Pathology, Faculty of Medicine and Dentistry, Universitat de València, 46010 Valencia, Spain., Farras R; Príncipe Felipe Research Center Foundation (CIPF), 46012 Valencia, Spain., Martín de Llano JJ; Department of Pathology, Faculty of Medicine and Dentistry, Universitat de València, 46010 Valencia, Spain.; INCLIVA Biomedical Research Institute, 46010 Valencia, Spain., Carda C; Department of Pathology, Faculty of Medicine and Dentistry, Universitat de València, 46010 Valencia, Spain.; INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicina (CIBER-BBN), 28029 Madrid, Spain., Mata M; Department of Pathology, Faculty of Medicine and Dentistry, Universitat de València, 46010 Valencia, Spain.; INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.; Biomedical Research Networking Center of Respiratory Diseases (CIBERES), 28029 Madrid, Spain.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Jun 17; Vol. 23 (12). Date of Electronic Publication: 2022 Jun 17.